Genfit SA Sponsored ADR Stock
Genfit SA Sponsored ADR Stock price
Key metrics
| Market capitalization | $167.74m |
| Enterprise Value | $174.33m |
| P/E (TTM) P/E ratio | 6.95 |
| EV/Sales (TTM) EV/Sales | 2.12 |
| P/S ratio (TTM) P/S ratio | 2.04 |
| P/B ratio (TTM) P/B ratio | 1.62 |
| Revenue growth (TTM) Revenue growth | 243.10% |
| Revenue (TTM) Revenue | $82.22m |
| EBIT (operating result TTM) EBIT | $17.52m |
Is Genfit SA Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.
Genfit SA Sponsored ADR Stock Analysis
Analyst Opinions
6 Analysts have issued a Genfit SA Sponsored ADR forecast:
Analyst Opinions
6 Analysts have issued a Genfit SA Sponsored ADR forecast:
Financial data from Genfit SA Sponsored ADR
| Jun '24 |
+/-
%
|
||
| Revenue | 82 82 |
243%
243%
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | 19 19 |
148%
148%
|
EBIT (Operating Income) EBIT | 18 18 |
142%
142%
|
| Net Profit | 24 24 |
167%
167%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Genfit SA Sponsored ADR directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Genfit SA Sponsored ADR Stock News
Company Profile
Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company focuses on the discovery and development of drug candidates in areas of high unmet medical needs corresponding to a lack of suitable treatments. It focuses on medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases, that affect the liver. The company was founded by Jean-François Mouney, Florence Séjourné and Bart Staels on September 1999 and is headquartered in Loos, France.
| Head office | France |
| CEO | Pascal Prigent |
| Founded | 1999 |
| Website | www.genfit.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
